Published in Biomed Res Int on August 25, 2013
Increased serum resistin levels correlate with psoriasis: a meta-analysis. Lipids Health Dis (2015) 0.76
A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea. Eur J Clin Microbiol Infect Dis (2016) 0.75
Effects of artemether on the proliferation, apoptosis, and differentiation of keratinocytes: potential application for psoriasis treatment. Int J Clin Exp Med (2015) 0.75
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature (2006) 13.75
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature (2007) 8.88
Pathogenesis and clinical features of psoriasis. Lancet (2007) 5.01
Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol (2009) 4.73
Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol (2009) 4.63
Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol (2012) 4.52
Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med (2005) 4.04
Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity (2011) 3.75
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet (2003) 3.52
Skin immune sentinels in health and disease. Nat Rev Immunol (2009) 3.52
Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol (2008) 3.11
Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med (2009) 2.66
Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med (2004) 2.63
Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol (2005) 2.49
Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol (2009) 2.46
Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today (1995) 2.09
Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc (2004) 1.95
Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies. Br J Dermatol (2012) 1.81
Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis. J Immunol (2011) 1.79
IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol (2009) 1.73
Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One (2010) 1.73
Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev (2009) 1.60
Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol (2011) 1.49
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol (2000) 1.37
Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol (2011) 1.24
New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol (2012) 1.21
An update on the genetics of psoriasis. Dermatol Clin (2004) 1.11
Psoriasis--as an autoimmune disease caused by molecular mimicry. Trends Immunol (2009) 1.09
Putting together the psoriasis puzzle: an update on developing targeted therapies. Dis Model Mech (2012) 1.09
Review paper: preclinical models of psoriasis. Vet Pathol (2008) 1.05
Animal models of psoriasis: a critical appraisal. Exp Dermatol (2008) 0.95
Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders. Lab Invest (2001) 0.92
Current and emerging systemic treatment strategies for psoriasis. Drugs (2012) 0.89
Psoriasis: from pathogenesis to novel therapeutic approaches. Clin Sci (Lond) (2011) 0.89
Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques. Exp Dermatol (2001) 0.85
Natural killer cells in psoriasis. J Innate Immun (2011) 0.85
Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol (2012) 0.84
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet (2004) 0.83
Combination treatments for psoriasis: a systematic review and meta-analysis. Arch Dermatol (2011) 0.82
Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 0.82
Advances in the treatment of moderate-to-severe plaque psoriasis. Am J Health Syst Pharm (2011) 0.80
Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol (2011) 0.79
Guidance on the diagnosis and clinical management of psoriasis. Clin Exp Dermatol (2012) 0.79
Topical psoriasis therapy. Am Fam Physician (1999) 0.78
The rationale behind topical vitamin d analogs in the treatment of psoriasis: where does topical calcitriol fit in? J Clin Aesthet Dermatol (2010) 0.77
A novel murine model of hypertrophic scarring using subcutaneous infusion of bleomycin. Plast Reconstr Surg (2014) 2.67
Regeneration of hair follicles is modulated by flightless I (Flii) in a rodent vibrissa model. J Invest Dermatol (2010) 1.44
TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res (2006) 1.02
Flightless I regulates hemidesmosome formation and integrin-mediated cellular adhesion and migration during wound repair. J Invest Dermatol (2009) 0.93
The role of the tetraspanin CD151 in primary keratinocyte and fibroblast functions: implications for wound healing. Exp Cell Res (2008) 0.89
IL-5-overexpressing mice exhibit eosinophilia and altered wound healing through mechanisms involving prolonged inflammation. Immunol Cell Biol (2008) 0.88
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. J Pathol (2011) 0.87
Regulation of MAPK activation, AP-1 transcription factor expression and keratinocyte differentiation in wounded fetal skin. J Invest Dermatol (2004) 0.86
Regulation of focal adhesions by flightless i involves inhibition of paxillin phosphorylation via a Rac1-dependent pathway. J Invest Dermatol (2011) 0.85
Flightless, secreted through a late endosome/lysosome pathway, binds LPS and dampens cytokine secretion. J Cell Sci (2012) 0.84
Decreased expression of Flightless I, a gelsolin family member and developmental regulator, in early-gestation fetal wounds improves healing. Mamm Genome (2011) 0.83
Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita. J Invest Dermatol (2012) 0.83
Flii neutralizing antibodies improve wound healing in porcine preclinical studies. Wound Repair Regen (2012) 0.80
Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes. Diabetologia (2013) 0.80
Mouse strains for the ubiquitous or conditional overexpression of the Flii gene. Genesis (2011) 0.80
Gender specific effects on the actin-remodelling protein Flightless I and TGF-beta1 contribute to impaired wound healing in aged skin. Int J Biochem Cell Biol (2007) 0.79
The influence of Flightless I on Toll-like-receptor-mediated inflammation in a murine model of diabetic wound healing. Biomed Res Int (2013) 0.79
Cytoskeletal protein Flightless (Flii) is elevated in chronic and acute human wounds and wound fluid: neutralizing its activity in chronic but not acute wound fluid improves cellular proliferation. Eur J Dermatol (2012) 0.78
Tropomyosin regulates cell migration during skin wound healing. J Invest Dermatol (2013) 0.78
Lysosomal secretion of Flightless I upon injury has the potential to alter inflammation. Commun Integr Biol (2012) 0.77
Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering. J Pathol (2014) 0.77
Lower vibrissa follicle amputation: a mammalian model of regeneration. Methods Mol Biol (2013) 0.77
Differential effects of insulin-like growth factors on scratch wound repair in respiratory epithelial cells. Am J Rhinol (2006) 0.76
Mitogenic bovine whey extract modulates matrix metalloproteinase-2, -9, and tissue inhibitor of matrix metalloproteinase-2 levels in chronic leg ulcers. Wound Repair Regen (2006) 0.76
Ultra-small AgNPs impregnated biocompatible hydrogel with highly effective biofilm elimination properties. ACS Appl Mater Interfaces (2020) 0.75